IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.

Yoichi NakayamaRyu WatanabeWataru YamamotoKosuke EbinaToru HiranoTakuya KotaniHideyuki ShibaMasaki KatayamaYonsu SonHideki AmuroAkira OnishiSadao JinnoRyota HaraKosaku MurakamiKoichi MurataHiromu ItoMasao TanakaShuichi MatsudaAkio MorinobuMotomu Hashimoto

Published in: Rheumatology (Oxford, England) (2023)

IL-6Ri and JAKi can effectively treat patients with anaemia and RA in a real-world setting.

Keyphrases

rheumatoid arthritis
disease activity
iron deficiency
ankylosing spondylitis
interstitial lung disease
systemic lupus erythematosus